CUBE · Cube Labs
AI read · Good for CUBE
The AI's read
The patent may make Cartilago more useful to Cube Labs through a license or sale. Cube Labs controls 51% of the startup, with another 12% held through a trust. The cream's collagen results come only from preclinical studies, and no deal or sales are reported. A simpler path for cosmetics could speed a launch, but no launch date is given.